Op-ed: Medicare changes could close 60% of Arizona’s long-term care pharmacies
By Dr. John Anwar | Published December 12, 2025 in Arizona Capitol Times
I had the honor of caring for my mother through the last years of her life as she fought stage 4 gastric cancer. Her care team consisted of internists, nurses and pharmacists, each leveraging their specialties to ensure my mother received the best care possible. This was a stark difference from our past, where at the age of 10 years, I watched my mother give birth prematurely to triplet brothers in our home in Egypt. The closest medical facility with specialized neonatal care was 300 miles away and financially out of reach for our family. Two of my brothers didn’t survive.
Being able to provide my mother with the accessible care she lacked as a young mother was the least I could do for her. It also embodied the principle that has guided my entire medical career: access to health care shouldn’t be determined by wealth or geography.
Today, tens of thousands of Arizonans face a similar crisis of distance and access. In less than a month, changes to Medicare Part D reimbursements could close up to 60% of long-term care (LTC) pharmacies across Arizona and the nation unless President Trump acts immediately. For the 91,965 Medicare beneficiaries in our state who depend on these pharmacies, this isn’t a policy debate — it’s a matter of survival.
LTC pharmacies are the backbone of care for Arizona’s most vulnerable residents. They serve nursing homes and assisted living facilities across our vast state, including rural communities where a single LTC pharmacy may be the only one serving dozens of facilities within hundreds of miles. These aren’t typical pharmacies — they manage complex medication regimens for patients who may take a dozen prescriptions daily, require specialized packaging, and need round-the-clock pharmaceutical support that federal law mandates senior care facilities must provide to operate.
This is exactly the kind of preventable crisis rooted in distance and inaccessible care that drove me into medicine. The difference is that this time, we have the power to act before tragedy strikes.
The Trump administration can offer immediate relief through demonstration projects or waivers — tools already within its statutory authority that require no congressional approval. Following that emergency action, Congress can pass the bipartisan Preserving Patient Access to Long-Term Care Pharmacies Act (H.R. 5031), which would establish a temporary supply fee per affected prescription to keep LTC pharmacies operational while we develop a sustainable funding model for such a necessary (and complex) business.
I’ve traveled thousands of miles and spent decades in medicine guided by a promise I made as a child: No one should lose access to care because of where they live or what they can afford. Arizona’s seniors in long-term care facilities — in Phoenix, Tucson, Flagstaff, and every small town in between — deserve that same promise kept.
That’s why I encourage President Trump to meet this critical moment and act with urgency.
Read the full article on Arizona Capitol Times here
Recent Posts
-
CMS Releases RFI on Part D Pharmacy Contracting Standards
Yesterday, CMS released a new Request for Information (RFI) seeking input on how it should establish “reasonable and relevant” pharmacy contracting standards in Medicare Part D, as required by the Consolidated Appropriations Act, 2026 (CAA). The new standards will apply beginning in plan year 2029. Importantly for long-term care (LTC) pharmacy, the RFI specifically asks […]
-
Pharmacy Group Wants CMS To Distinguish LTCs From Retailers Through RFI
Lauren Brensel // Inside Health Policy – September 16, 2026 A trade association representing long-term care pharmacies (LTCs) is hoping CMS will use an upcoming request for information to establish guidance on contracting issues like reimbursement rates and network adequacy standards that could differ for retail pharmacies. The group has met with CMS to discuss […]
-
SCPC Submits Pre-Comment Letter on Medicare Part D Pharmacy Contracting Standards
SCPC submitted a pre-comment letter to CMS outlining key long-term care (LTC) pharmacy considerations as the agency prepares its Request for Information on “reasonable and relevant” Medicare Part D pharmacy contracting standards. The letter highlights LTC-specific issues related to reimbursement, network access, contracting practices, audits, beneficiary protections, and other Part D contracting challenges. Read SCPC’s […]
Stay Connected
Get the latest news and updates on issues impacting the long-term care pharmacy community.